Delayed clinical trials for long Covid to begin; the crisis in gene therapy

The NIH on Monday took long-delayed steps to begin enrolling patients in clinical trials to test long Covid treatments.

July 31, 2023 Check out STAT+

Sponsored By

Molly Ferguson for STAT STAT+ | Gene therapy is in crisis. For nine hours, the field's leading minds looked for a solution With the field struggling, top scientists searched for a way to bring gene therapy to the millions of rare disease patients. By Jason Mast NIH begins long-delayed clinical trials for long Covid, announces new research office The NIH's new long Covid clinical trials will look at treatments related to viral persistence, brain fog, fatigue, heart rate, and more. By Rachel Cohrs STAT+ | Sage hopes for a blockbuster in fast-acting antidepressant now before FDA The antidepressant, called zuranolone, is designed to kick in within the first three days of treatment and be stopped after 14 days. By Brittany Trang SERGIO FLORES/AFP via Getty Images Vivek Ramaswamy wants to 'gut' the FDA. His claims don't hold up to scrutiny Vivek Ramaswamy, the former biotech exec and current presidential candidate, has thoughts on the FDA. They don't all hold up to scrutiny. By Adam Feuerstein and Matthew Herper As wildfires burn, scientists race to understand the health dangers of prolonged exposure Emerging evidence suggests particulates in wildfire smoke are more problematic than other types of air pollution, especially for lung health. By Megan Molteni STAT+ | New safety details link Apellis eye drug to rare cases of blindness. Cause still unknown The new safety information was presented by a committee of eye disease experts at a meeting of the American Society of Retinal Specialists. By Adam Feuerstein Seth Wenig/AP National panel will explore requiring free Covid tests The USPSTF will discuss recommending Covid-19 screening, the first step in requiring insurers to cover the tests at no cost to patients. By Sarah Owermohle STAT+ | Medicare wants to improve Alzheimer's care, but sidesteps drug prices Medicare pilot aims to improve dementia care and reduce stress on unpaid caregivers, but it sidesteps Alzheimer's drug costs. By John Wilkerson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser